** Shares of medical equipment maker West Pharmaceutical Services WST.N rise 12.9% to $256.5 premarket
** Company expects annual adj. profit in the range of $6.65 to $6.85 per share, compared with previous range of $6.15 to $6.35 per share
** Forecasts annual sales in the range of $3.04 billion to $3.06 billion, compared with $2.95 billion to $2.98 billion projected earlier
** Company posts Q2 adj. profit of $1.84 per share, beating analysts' estimate of $1.51 per share - data compiled by LSEG
** Reports Q2 sales of $766.5 million, while analysts estimated $727.5 million
** Up to last close, shares down 30.6% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))